Gain Therapeutics Inc (GANX)
3.03
-0.04
(-1.30%)
USD |
NASDAQ |
Apr 26, 16:00
3.00
-0.03
(-0.99%)
After-Hours: 20:00
Gain Therapeutics Price: 3.03 for April 26, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Apr 26, 2024 | 3.09 | 3.18 | 2.887 | 3.03 | 178990.0 |
| Apr 25, 2024 | 3.10 | 3.20 | 2.95 | 3.07 | 142421.0 |
| Apr 24, 2024 | 3.54 | 3.65 | 3.12 | 3.19 | 146812.0 |
| Apr 23, 2024 | 3.13 | 3.39 | 3.070 | 3.39 | 66437.00 |
| Apr 22, 2024 | 3.27 | 3.43 | 3.12 | 3.17 | 53675.00 |
| Apr 19, 2024 | 3.11 | 3.26 | 3.00 | 3.18 | 71353.00 |
| Apr 18, 2024 | 3.19 | 3.32 | 3.10 | 3.15 | 78261.00 |
| Apr 17, 2024 | 3.16 | 3.271 | 3.10 | 3.18 | 80646.00 |
| Apr 16, 2024 | 3.10 | 3.19 | 2.925 | 3.16 | 111460.0 |
| Apr 15, 2024 | 3.10 | 3.230 | 3.02 | 3.09 | 81897.00 |
| Apr 12, 2024 | 3.262 | 3.323 | 3.01 | 3.15 | 124939.0 |
| Apr 11, 2024 | 3.34 | 3.405 | 3.25 | 3.36 | 47628.00 |
| Apr 10, 2024 | 3.31 | 3.39 | 3.10 | 3.34 | 79671.00 |
| Apr 09, 2024 | 3.41 | 3.53 | 3.30 | 3.38 | 63783.00 |
| Apr 08, 2024 | 3.57 | 3.638 | 3.31 | 3.43 | 76272.00 |
| Apr 05, 2024 | 3.57 | 3.72 | 3.49 | 3.56 | 105241.0 |
| Apr 04, 2024 | 4.04 | 4.04 | 3.450 | 3.58 | 177370.0 |
| Apr 03, 2024 | 3.82 | 4.04 | 3.74 | 3.99 | 58740.00 |
| Apr 02, 2024 | 4.00 | 4.00 | 3.82 | 3.89 | 92070.00 |
| Apr 01, 2024 | 4.00 | 4.00 | 3.57 | 3.83 | 129119.0 |
| Mar 28, 2024 | 3.69 | 3.95 | 3.68 | 3.77 | 102217.0 |
| Mar 27, 2024 | 3.84 | 3.895 | 3.600 | 3.73 | 114019.0 |
| Mar 26, 2024 | 3.65 | 3.958 | 3.57 | 3.80 | 145673.0 |
| Mar 25, 2024 | 4.10 | 4.10 | 3.55 | 3.65 | 210378.0 |
| Mar 22, 2024 | 4.37 | 4.445 | 3.80 | 4.06 | 246921.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.07
Minimum
Nov 21 2023
15.80
Maximum
Apr 05 2021
5.133
Average
4.09
Median
Mar 30 2022
Price Benchmarks
| Eli Lilly and Co | 733.51 |
| Alpine Immune Sciences Inc | 64.56 |
| Outlook Therapeutics Inc | 8.43 |
| Greenwich LifeSciences Inc | 13.12 |
| CEL-SCI Corp | 1.44 |
Price Related Metrics
| PEG Ratio | -0.0566 |
| Price to Book Value | 3.869 |
| Earnings Yield | -57.00% |
| Market Cap | 48.66M |
| PEGY Ratio | -0.0566 |